Chai Discovery builds generative AI foundation models that predict and design protein and antibody structures to accelerate pre-clinical drug discovery.

Clinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.